Product: Actoplus met XR (pioglitazone and metformin HCl, extended-release) tablets, 15 mg/1000 mg, Rx Only, 30 tablet bottle, Distributed by: Takeda Pharmaceuticals  America, Inc, Deerfield, IL 60015.  NDC: 64764-510-30
Reason for recall: Defective Delivery System: tablets may be missing, in whole or in part, the laser drilled holes on the metformin core of the Actoplus met XR tablets.
Recall initiated: 20180910
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated